ReportsnReports

DNA Sequencing 2012: Market Needs, Emerging Developments and Future Use

 
Repost This

Dallas, TX -- (SBWIRE) -- 09/17/2012 -- ReportsnReports.com adds new market research report "DNA Sequencing 2012: Market Needs, Emerging Developments and Future Use" to its store.

Key Findings
- Routine use: Use of flow cytometry DNA sequencing by end-users for routine (developed and validated) DNA sequencing tests, the development or validation of DNA sequencing tests and for qualitative discovery using DNA sequencing methods.
- Companies: End-users purchases/use of DNA sequencing systems from more than 30 companies and their anticipated use of these systems by end-users over the next three years, each ranked according to their competitive position
- DNA sequencing techniques: Current use of more than 15 DNA sequencing techniques by end-users and their anticipated use of these techniques over the next three years, each ranked according to their competitive position.
- DNA sequencing applications: Current use of more than 12 DNA applications by end-users and their anticipated use of these applications over the next three years, each ranked according to their competitive position.
- Preferred Company: End-users’ preferred Company supplier in the DNA sequencing field, each ranked according to their competitive position.
- Preferred Product: End-users’ preferred product in the DNA sequencing field, each ranked according to their competitive position.
- Strengths: End-users’ disclosures of the strengths of their preferred product in the DNA sequencing field, each ranked according to their competitive position.
- Weaknesses: End-users’ disclosures of the weaknesses of their preferred product in the DNA sequencing field, each ranked according to their competitive
- Annual Financial Budgets: End-users’ annual financial budgets for DNA sequencing studies.
- Budget Breakdown: The breakdown of end-users’ current DNA sequencing financial budgets in eight key areas and their anticipated budget breakdown in these areas over the next three years.
- Future Financial Budgets: End-users’ anticipated financial budget changes (percentage increases or decrease) over the next three years, relating to their DNA sequencing activities
- Consumables: End-users’ top consumables, associated with their DNA sequencing activities.
- Quality Control Guidelines: End-users’ adherence to quality control guidelines or procedures, relating to the conduct of DNA sequencing studies.
- Current Challenges: End-users’ disclosures on molecular types that present the greatest technical challenges to DNA sequencing analysis, together with the associated sample types (matrices), associated DNA sequencing methods and the underlying reasons.
- Required Innovation: End-users’ disclosures relating to 12 key areas of required innovation in the DNA sequencing field, each ranked (on a scale of 1 to 10) according to their importance.
- Recent Innovations: End-users disclosures on the most important innovations relating to their use of DNA sequencing, over the last three years.
- Future Innovation: End-users’ disclosures on what they anticipate will be the most important innovations in the DNA sequencing, over the next three years.
- Biomarkers: End-users’ application of DNA sequencing methods for the study of disease biomarkers, namely molecular types and their clinical utilities.
- Organisations: End-users organisations include clinics or hospitals, government bodies, large international companies, research institutes, small and medium sized companies, universities and veterinary centres.
- Fields: End-users professional fields include biotechnology, chemicals, clinical or hospital, defence, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security and universities.
- Therapeutic Areas: End-users’ DNA sequencing activities in terms of their general therapeutic area (20 different areas covered), including the main diseases with which their work is concerned.
- Bioinformatics software: End-users’ disclosures on their preferred bioinformatics software, associated with DNA sequencing studies.
- Purpose: End-users’ underlying reasons for using DNA sequencing analysis across 17 major fields (biotechnology, chemicals, clinical or hospital, defence, diagnostics (medical), energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security, university), each ranked according to their relative importance.
- Study Samples: Study sample types analysed by end-users using DNA sequencing methods, each ranked according to their relative importance.
- Sample Preparation: The use of sample preparation methods by end-users for DNA sequencing studies, each ranked according to their importance.

Buy your copy of this report @ http://www.reportsnreports.com/reports/190675-dna-sequencing-2012-market-needs-emerging-developments-and-future-use.html . Contact sales@reportsandreports.com for further information.